BackAyala Pharmaceuticals Overview

Ayala Pharmaceuticals Research & Development

Research & Development expenses for AYLA.

Quarterly R&D Expenses

$7.57M
↑ 0.6% YoY

As of Dec 31, 2022

Annual R&D Expenses (TTM)

$27.85M
↓ 6.98% YoY

Trailing 12 months ending Dec 31, 2022

Average R&D Expenses (Comparison Companies)

Research & Development History

Research & Development Comparison

Annual Research & Development Growth Rate (%)

Annual Research & Development Growth (Absolute)

Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin